Posted in | News | Military Robotics

Raytheon to Supply Scalable Sonar System for Anti-Submarine/Undersea Warfare Missions

Raytheon Company was awarded a sub-contract from Science Applications International Corporation (SAIC) to deliver its first 5th generation medium frequency hull mounted sonar system as part of the Defense Advanced Research Projects Agency (DARPA) Anti-Submarine Warfare Continuous Trail Unmanned Vessel (ACTUV) program.

According to the U.S. Navy, 43 nations operate more than 600 submarines; the steady increase in undersea vessels makes tracking a challenge. Raytheon's Modular Scalable Sonar System (MS3) will integrate into SAIC's prototype trimaran vessel as the primary search and detection sonar. The system is designed to provide search, detection, passive-threat filtering, localization and tracking capabilities without requiring human operation.

MS3 enables anti-submarine warfare (ASW) and undersea warfare with capabilities such as active and passive search, torpedo detection and alertment, and small object avoidance. Data from multiple sonars may be fed to a central command and control node, providing a common operating picture as part of the ASW mission. By integrating a host of capabilities in a single sonar system, Raytheon delivers an affordable solution that addresses critical naval challenges.

"Historically, manned sonars were central to anti-submarine warfare missions. However, the growing number of submarines traversing the world's oceans makes this model unsustainable," said Joe Biondi , vice president of Advanced Technology for Raytheon's Integrated Defense Systems business. "By leveraging Raytheon's heritage in developing undersea sensors, MS3 can be configured to provide the capabilities required for ASW in an autonomous environment."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.